These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. FAAH levels and its genetic polymorphism association with susceptibility to methamphetamine dependence. Zhang W; Liu H; Deng XD; Ma Y; Liu Y Ann Hum Genet; 2020 May; 84(3):259-270. PubMed ID: 31789429 [TBL] [Abstract][Full Text] [Related]
5. Association of NQO1 levels and its genetic polymorphism with susceptibility to methamphetamine dependence. Liu H; Zhang W; Deng XD; Ma Y; Liu Y Mol Genet Genomic Med; 2021 Oct; 9(10):e1789. PubMed ID: 34467676 [TBL] [Abstract][Full Text] [Related]
6. Methamphetamine-induced behavioral sensitization is enhanced in the HIV-1 transgenic rat. Liu X; Chang L; Vigorito M; Kass M; Li H; Chang SL J Neuroimmune Pharmacol; 2009 Sep; 4(3):309-16. PubMed ID: 19444617 [TBL] [Abstract][Full Text] [Related]
7. Methamphetamine use and neuropsychiatric factors are associated with antiretroviral non-adherence. Moore DJ; Blackstone K; Woods SP; Ellis RJ; Atkinson JH; Heaton RK; Grant I; AIDS Care; 2012; 24(12):1504-13. PubMed ID: 22530794 [TBL] [Abstract][Full Text] [Related]
8. Association of GABA receptor delta subunit gene variations with increased risk of methamphetamine dependence. Xie X; Zhuang D; Gu J; Wu T; Shen W; Li L; Liu Y; Xu W; Hong Q; Xu Z; Chen W; Zhou W; Liu H Neurosci Lett; 2023 Mar; 800():137137. PubMed ID: 36804572 [TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings. Cherner M; Bousman C; Everall I; Barron D; Letendre S; Vaida F; Atkinson JH; Heaton R; Grant I; J Int Neuropsychol Soc; 2010 Sep; 16(5):890-901. PubMed ID: 20727252 [TBL] [Abstract][Full Text] [Related]
10. The Effects of BDNF Val66Met Gene Polymorphism on Serum BDNF and Cognitive Function in Methamphetamine-Dependent Patients and Normal Controls: A Case-Control Study. Su H; Tao J; Zhang J; Xie Y; Wang Y; Zhang Y; Han B; Lu Y; Sun H; Wei Y; Zou S; Wu W; Zhang J; Xu K; Zhang X; He J J Clin Psychopharmacol; 2015 Oct; 35(5):517-24. PubMed ID: 26280836 [TBL] [Abstract][Full Text] [Related]
11. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. Rippeth JD; Heaton RK; Carey CL; Marcotte TD; Moore DJ; Gonzalez R; Wolfson T; Grant I; J Int Neuropsychol Soc; 2004 Jan; 10(1):1-14. PubMed ID: 14751002 [TBL] [Abstract][Full Text] [Related]
12. Role of dopamine D3 receptors in methamphetamine-induced behavioural sensitization and the characterization of dopamine receptors (D1R-D5R) gene expression in the brain. Su H; Wang X; Bai J; Fan Y; Du Y; Wei Z; Yan J; Yun K; Chen T Folia Neuropathol; 2022; 60(1):105-113. PubMed ID: 35359150 [TBL] [Abstract][Full Text] [Related]
13. MRP8/14 Is a Molecular Signature Triggered by Dopamine in HIV Latent Myeloid Targets That Increases HIV Transcription and Distinguishes HIV+ Methamphetamine Users with Detectable CSF Viral Load and Brain Pathology. Basova LV; Lindsey A; McGovern A; Rosander A; Delorme-Walker V; ElShamy WM; Pendyala VV; Gaskill PJ; Ellis RJ; Cherner M; Iudicello JE; Marcondes MCG Viruses; 2023 Jun; 15(6):. PubMed ID: 37376663 [TBL] [Abstract][Full Text] [Related]
14. Dopamine and its receptors play a role in the modulation of CCR5 expression in innate immune cells following exposure to Methamphetamine: Implications to HIV infection. Basova L; Najera JA; Bortell N; Wang D; Moya R; Lindsey A; Semenova S; Ellis RJ; Marcondes MCG PLoS One; 2018; 13(6):e0199861. PubMed ID: 29944719 [TBL] [Abstract][Full Text] [Related]
15. Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosis. Iamjan SA; Thanoi S; Watiktinkorn P; Reynolds GP; Nudmamud-Thanoi S J Psychopharmacol; 2018 Mar; 32(3):309-315. PubMed ID: 29338492 [TBL] [Abstract][Full Text] [Related]
16. Sustained attention and vigilance deficits associated with HIV and a history of methamphetamine dependence. Pocuca N; Young JW; MacQueen DA; Letendre S; Heaton RK; Geyer MA; Perry W; Grant I; Minassian A; Drug Alcohol Depend; 2020 Oct; 215():108245. PubMed ID: 32871507 [TBL] [Abstract][Full Text] [Related]
17. Persistent cognitive and dopamine transporter deficits in abstinent methamphetamine users. McCann UD; Kuwabara H; Kumar A; Palermo M; Abbey R; Brasic J; Ye W; Alexander M; Dannals RF; Wong DF; Ricaurte GA Synapse; 2008 Feb; 62(2):91-100. PubMed ID: 17992686 [TBL] [Abstract][Full Text] [Related]
18. Genetic variants of D2 but not D3 or D4 dopamine receptor gene are associated with rapid onset and poor prognosis of methamphetamine psychosis. Ujike H; Katsu T; Okahisa Y; Takaki M; Kodama M; Inada T; Uchimura N; Yamada M; Iwata N; Sora I; Iyo M; Ozaki N; Kuroda S Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):625-9. PubMed ID: 19275926 [TBL] [Abstract][Full Text] [Related]
19. The adenosine A2A receptor is associated with methamphetamine dependence/psychosis in the Japanese population. Kobayashi H; Ujike H; Iwata N; Inada T; Yamada M; Sekine Y; Uchimura N; Iyo M; Ozaki N; Itokawa M; Sora I Behav Brain Funct; 2010 Aug; 6():50. PubMed ID: 20799992 [TBL] [Abstract][Full Text] [Related]
20. Mouse strain- and age-dependent effects of binge methamphetamine on dopaminergic signaling. Good RL; Liang LP; Patel M; Radcliffe RA Neurotoxicology; 2011 Dec; 32(6):751-9. PubMed ID: 21798282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]